Ключевые слова:
хронические миелопролиферативные неоплазии, тромбозы, генетические полиморфизмы, гены метаболизма фолатов.Библиографические ссылки
Andreenko E.Ju., L.M. Samohodskaja, A.V. Balackij, P.I. Makarevich, S.A. Bojcov //Prognosticheskaja znachimost' nositel'stva allel'nyh variantov genov, kontrolirujushhih sistemu gemostaza, i ih sochetanija s tradicionnymi faktorami riska v rannem razvitii ishemicheskoj bolezni serdca/Kardiovaskuljarnaja terapija i profilaktika. 2011. T. 10, № 8. S. 32-39.
Blinova E.A., Grebennikova I.V. Jetiologija i patogenez trombofilii // Mezhdunarodnyj studencheskij nauchnyj vestnik. – 2016. – №4-2. - S.143-144.
Vasil'ev S.A., Vinogradov V.L., Smirnov A.N. i dr. Trombozy i trombofilii: klassifikacija, diagnostika, lechenie, profilaktika // RMZh. Medicinskoe obozrenie. – 2013. – T.21, №17. – S.896.
Vorob'ev A.I., Vasil'ev S.A., Gorodeckij V.M., Shavelov A.A., Gorgidze L.A., Kremeneckaja O.S., Shklovskij-Kordi H.E. Giperkoaguljacionnyj sindrom: klassifikacija, patogenez, diagnostika, terapija // Gematologija i transfuziologija. - 2016. - №3. - S.116-122.
Melikjan A.L., A.G. Turkina, K.M. Abdulkadyrov [i dr.] /Klinicheskie rekomendacii po diagnostike i terapii Ph-negativnyh mieloproliferativnyh zabolevanij (istinnaja policitemija, jessencial'naja trombocitemija, pervichnyj mielofibroz) // Gematologija i transfuziologija. - 2014. - T. 59, № 4. -S. 31-56.;
Samojlenko V.V. Trombofilija: diagnostika i lechenie. Mesto i rol' laboratornoj diagnostiki // Trombozy i trombofilii v praktike vracha-flebologa. Nauch.-praktich. konf. – M., 2018. – C.24-26.
Fetisova I.N., Dobroljubov A.S., Lipin M.A., Poljakov A.V. Polimorfizm genov folatnogo obmena i bolezni cheloveka // Vestnik novyh medicinskih tehnologij. – 2007. – T. H, № 1. –S.
Filatova E.A., Esenina T.V., Mishkurova K.M., Fedorova H.A. Nasledstvennaja gematogennaja trombofilija, manifestirujushhaja trombojemboliej legochnoj arterii // Amurskij med. zhurnal. – 2018. - №1-2 (20-21). – S.25-29.
Barbosa P.R., Stabler S.P., Machado A.L., et al. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women // Eur J Clin Nutr. 2008 Aug;62(8):1010-21.
Butt C., Zheng H., Randell E. e.a. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction // Blood.- 2021.- V.102, N 4.- P. 1558-1559.
Cai B., Zhang T., Zhong R., et al. Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis // PLoS One. 2014; 9(3):e89609.
Duangnapasatit D., E. Rattarittamrong, T. Rattanathammethee/ Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms //Asian Pac J Cancer Prev. - 2015. - Vol.16(12). - P. 5013-5018
Feix A., Winkelmayer W.C., Eberle C., et al. Methionine synthase reductase MTRR 66A>G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients // Atherosclerosis. 2004; 174:43–8.
Kurzawińska G., Seremak-Mrozikiewicz A., Drews K., Barlik M., Mrozikiewicz P.M. [Genetic conditioned changes in activity of 5,10-methylenetetrahydrofolate reductase (MTHFR) and recurrent miscarriages]. [Article in Polish] // Ginekol Pol. 2009 Oct;80(10):762-7.
Mahmoodi B K 1, J-L P Brouwer, M K Ten Kate, W M Lijfering, N J G M Veeger, A B Mulder, H C Kluin-Nelemans, J Van Der Meer. Venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin J Thromb Haemost. 2018 Jun;8(6):1193-200. doi: 10.1111/j.1538-7836.2010.03840.x. Epub 2018 Mar 4.
Martiskainen M., Pohjasvaara T., Mikkelsson J. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke // Stroke.- 2020.- V. 34, N 4.- P. 886-891
Noori N., Miri-Moghaddam E., Dejkam A., et al. Are polymorphisms in MTRR A66G and MTHFR C677T genes associated with congenital heart diseases in Iranian population? // Caspian J Intern Med. 2017 Spring;8(2):83-90.
Pishva S.R., Vasudevan R., Etemad A., et al. Analysis of MTHFR and MTRR Gene Polymorphisms in Iranian Ventricular Septal Defect Subjects // Int J Mol Sci. 2013 Jan 28; 14(2):2739-52.
Ramzi M., N. Cohan, M. Yavarian, M.R. Jahromi // Coagulation factor VII gene polymorphisms and cardiovascular diseases in Iranian population / J. Indian College of Cardiology. 2013. Vol. 3, No 1. P. 6-8. DOI: 10.1016/j.jicc.2012.12.004
Rosendaal F.R., Siscovick D.S., Schwartz S.M. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women // Blood.- 2017.- V. 90, N 5.- P. 1747-1750
Semmler A., Moskau-Hartmann S., Stoffel-Wagner B., et al. Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism // Clin Chem Lab Med. 2013 Mar 1;51(3):665-9.
Szotowski B., Antoniak S., Poller W. et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines // Cir. Res. — 2019. — No 12. — P. 1233–1239.
Yu D., Yang L., Shen S., et al. Association between methionine synthase reductase A66G polymorphism and the risk of congenital heart defects: evidence from eight case-control studies // Pediatr Cardiol. 2014 Oct;35(7):1091-8.